Philidor Rx Services

Last updated
Philidor Rx Services
Industry Pharmaceutical industry specialty pharmacy
Founded2 January 2013 (2 January 2013) [1]
Headquarters Hatboro, Pennsylvania [2]
Key people
Andrew (Andy) Davenport CEO and founder
Matthew Davenport
Gretchen Wisehart, general counsel for Phillidor [1]
Gregory W. Blaszczynski, CFA [3]
Productsonline specialty pharmacy
Servicesspecialty pharmacy prescription-filling mail-order business
Number of employees
950
Website Official website

Philidor Rx Services is a Pennsylvania-licensed specialty online pharmacy, which mainly sold [4] [5] Valeant Pharmaceuticals International Inc drugs directly to patients and handled insurance claims on the customers' behalf. [1] [6]

Contents

BQ6 Media Group LLC

BQ6 Media Group LLC is a "privately held marketing firm specializing in pharmaceutical marketing, communications and promotion" [7] based in Philadelphia, PA, [8] with its headquarter in Horsham, PA, a group that did consulting work for Valeant, among other pharmaceutical companies. [2] BQ6 Media, which is located just four kilometres from Philidor's head office, [9] self-defined as game theorists that combined "creative vision with empirical data and market expertise." [10] On their webpage they offer to help clients in the pharmaceutical industry "ensure your brand is moves ahead" using zero-sum game theory concepts. [10] They develop "innovative strategies" to move pharmaceutical products from "pipeline to endgame." [11] Philidor is part of a network of companies, including BQ6 Media Group LLC and Isolani LLC. Philidor RX Services created Isolani LLC. The name Philidor refers to an 18th-century French Chess master Francois-Andre Philidor and the Philidor position, an important chess Chess endgame; isolani refers to an isolated pawn. [12] BQ6 Media is named after the chess shorthand for Bobby Fischer's legendary move against Russian chess master Boris Spassky in 1972. [9] [13] The Southern Investigative Reporting Foundation (SIRF) report alleges that several states list Matthew Davenport, David Wing, John Carne and Gregory Blaszcynski as officers of BQ6 Media and another company, End Game Partnership LLP (chess reference), as assistant treasurer. [13] The SIRF report pointed to another reference to a popular chess move called the King's Gambit Accepted (KGA) that is also the name of Valeant's wholly owned unit — KGA Fulfillment Services Inc., formed in Delaware in November 2014. [9]

History

Philidor Rx Services was formed in 2013 by Matthew S. Davenport and Andrew (Andy) Davenport as an online pharmacy in Delaware [2] with an office in Horsham, Pennsylvania and in Hatboro, [2] a town of about 7,360 in Montgomery County, Pennsylvania. [14]

California is the "largest market for medicines" in the US [6] and Philidor and Valeant faced "hurdles in getting prescriptions filled there. [6] In August 2013 Philidor had requested an application for a California Non-Residency Pharmacy Permit but it was denied in May 2014 by State Attorney General Kamala Harris's staff because Philidor allegedly falsified information on its application, claiming that Matthew Davenport was registered as Philidor's principal when Andrew (Andrew) Davenport was the principal and did not disclose that Andrew owned 27% of Philidor. There were other "false statement of facts" on the application and Philidor was accused of unprofessional conduct. [6] [15]

On December 1, 2014, 64-year-old pharmacist Russell Reitz sold his small three-year-old specialty pharmacy prescription-filling mail-order business — R&O Pharmacy — in Camarillo, in suburban Los Angeles for $350,000 to Isolani LLC. Reitz stayed on as manager. [6] Prior to the acquisition by Isolani, R&O Pharmacy had dispensed a modest number of prescription medications to patients and collected reimbursements from insurance companies. With the new owners, Isolani and Philidor, Reitz' store's name R&O Pharmacy, and his National Council for Prescription Drug Programs identification number were used to fill prescriptions nationwide at other pharmacies which amounted to $230 million a year. Reitz became concerned and in July he sent emails to Andy Davenport CEO of Philidor and Eric Rice of Isolani. In the emails Reitz, claimed that his personal "ID was used to bill for prescriptions" that were "filled by some other pharmacy (in some cases for drugs that R&O did not even stock)" or "filled and billed" before the R&O purchase agreement was finalized. [16]

Another pharmacy in the Philidor network is West Wilshire Pharmacy in Los Angeles. [6]

According to a Wall Street Journal article in October 2015, "Valeant employees were placed at Philidor while the pharmacy was in its infancy" to provide help on "structures and processes." [2] In 2014, Philidor created 250 new jobs. In an October 26, 2015 conference call Valeant CEO J. Michael Pearson said, Valeant had paid $100 million in late 2014 for an option to buy Philidor for nothing over the next 10 years. In turn Philidor "has an option to buy a Delaware entity called Isolani LLC, which has an agreement to buy" Camarillo, California-based specialty pharmacy R&O Pharmacy. [17]

Specialty pharmacies

Most of the prescriptions filled by Philidor were for Valeant's expensive drugs like Solodyn, an oral antibiotic approved to treat moderate to severe acne and Jublia, [2] [18] a treatment for onychomycosis of the toenails. [19] They also filled Retin-A Micro Tretinoin prescriptions. [19] Jublia, which received FDA approval in July 2014 and Retin-A Micro, which received FDA approval in January 2014, [20] were two products among others that Valeant acquired with the purchase of Dow Pharmaceuticals in 2008. [19] [20]

By October 2015, a "bottle of 30 of Solodyn tablets can cost up to $1,040.41" and an "8-milliliter bottle of Jublia costs $1,075.72" according to "Truven Health Analytics, which publishes average wholesale prices." [21]

According to ProPublica, [22]

"Specialty pharmacies are seen as a reliable distribution channel for expensive drugs, offering patients convenience and lower costs while maximizing insurance reimbursements from those companies that cover the drug. Patients typically pay the same co-payments whether or not their insurers cover the drug."

— ProPublica 22 October 2015

According to Reuters, "Specialty pharmacies are designed to handle medicines that require complex storage or administration, often for serious conditions such as cancer or rheumatoid arthritis. Valeant has used Philidor to dispense a range of its medications, including conventional treatments for acne and toenail fungus." [23]

Valeant and Philidor

Tactics used by Philidor Rx Services were challenged in a 2015 investigation of Philidor's partner company, Valeant Pharmaceuticals International Inc. [24] During the October investigations Valeant disclosed that it has an option to buy Philidor RX Services. [25] Valeant's stocks have decreased in value as a result of these allegations. [25]

According to "former employees and an internal document", Philidor who filled Valeant's prescriptions "altered doctors’ orders to wring more reimbursements out of insurers." [5]

Valeant employees who worked at Philidor in the early months of Philidor's operations, "set up separate Philidor email accounts, under "clearly distinguishable names," to keep “their internal Philidor communications separate from the Valeant communications, primarily to reduce the risk of incorrectly sharing either company’s proprietary information." One alleged practice entailed Valeant employees directly managing Philidor's business operations while posing as Philidor employees and with all written communication under fictitious names. [26] For example, Bijal Patel, a manager of access solutions at Valeant in Scottsdale, Arizona used the email name of Peter Parker, the alter ego of Spider-Man at Philidor where he tracked prescriptions. [2]

In October 2015, major pharmacy benefit management (PBM) organizations — such as Express Scripts — the largest PBM organization in the United States [27] — began reviewing pharmacy programs run by AbbVie Inc and Teva Pharmaceuticals Industries Ltd regarding the potential use of tactics employed by Philidor that "can allow drugmakers to work around reimbursement restrictions" from Express Scripts and other insurers. Insurers like Express Scripts direct "patients to cheaper generic versions of widely-used medicines to save costs." [24]

A major allegation is that, by controlling the pharmacy services offered by Philidor, Valeant steered Philidor's customers to expensive drugs sold by Valeant. [26]

On October 22, Alex Arfaei, an analyst with BMO Capital Markets — who has promoted Valeant's stock purchase since 2013 — questioned Valeant's close ties to specialty pharmacies that distribute its drugs arguing that Valeant's arrangements with the specialty was "not just aggressive, but questionable" and that BMO "cannot defend the specialty pharmacy structure." [25]

Valeant responded that Citron Research group accusations that Valeant was the 'Pharmaceutical Enron' were "erroneous." [28]

On October 30, Valeant cut ties with Philidor. [4] [5]

Related Research Articles

<span class="mw-page-title-main">Pharmacy</span> Clinical health science

Pharmacy is the science and practice of discovering, producing, preparing, dispensing, reviewing and monitoring medications, aiming to ensure the safe, effective, and affordable use of medicines. It is a miscellaneous science as it links health sciences with pharmaceutical sciences and natural sciences. The professional practice is becoming more clinically oriented as most of the drugs are now manufactured by pharmaceutical industries. Based on the setting, pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care in the community of institutional pharmacies is considered clinical pharmacy.

<span class="mw-page-title-main">Medical prescription</span> Health-care communication from a physician to a pharmacist

A prescription, often abbreviated ℞ or Rx, is a formal communication from a physician or other registered healthcare professional to a pharmacist, authorizing them to dispense a specific prescription drug for a specific patient. Historically, it was a physician's instruction to an apothecary listing the materials to be compounded into a treatment—the symbol ℞ comes from the first word of a medieval prescription, Latin recipere, that gave the list of the materials to be compounded.

Prescription drug list prices in the United States continually are among the highest in the world. The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015. One major reason for high prescription drug prices in the United States relative to other countries is the inability of government-granted monopolies in the American health care sector to use their bargaining power to negotiate lower prices, and the American payer ends up subsidizing the world's R&D spending on drugs.

<span class="mw-page-title-main">Prescription drug</span> Medication legally requiring a medical prescription before it can be dispensed

A prescription drug is a pharmaceutical drug that is permitted to be dispensed only to those with a medical prescription. In contrast, over-the-counter drugs can be obtained without a prescription. The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license and without sufficient education. Different jurisdictions have different definitions of what constitutes a prescription drug.

Pharmaceutical marketing is a branch of marketing science and practice focused on the communication, differential positioning and commercialization of pharmaceutical products, like specialist drugs, biotech drugs and over-the-counter drugs. By extension, this definition is sometimes also used for marketing practices applied to nutraceuticals and medical devices.

<span class="mw-page-title-main">Secobarbital</span> Obsolete sedative-hypnotic

Secobarbital is a short-acting barbiturate derivative drug that was patented in 1934 in the United States. It possesses anaesthetic, anticonvulsant, anxiolytic, sedative, and hypnotic properties. In the United Kingdom, it was known as quinalbarbitone. It is the most frequently used drug in physician-assisted suicide within the United States. Secobarbital is considered to be an obsolete sedative-hypnotic, and as a result, it has largely been replaced by the benzodiazepine family. Seconal was widely abused, known on the street as "red devils" or "reds". Among the barbiturates, secobarbital carries a particularly high risk of abuse and addiction, largely responsible for its falling out of use.

Bausch Health Companies Inc. is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products. Bausch Health's business model is primarily focused on acquiring small pharmaceutical companies and then sharply increasing the prices of the drugs these companies sell.

<span class="mw-page-title-main">Etacrynic acid</span> Chemical compound

Etacrynic acid (INN) or ethacrynic acid (USAN), trade name Edecrin, is a loop diuretic used to treat high blood pressure and the swelling caused by diseases like congestive heart failure, liver failure, and kidney failure. A con with ethacrynic acid compared to the other loop diuretic drugs such as furosemide is that it has a significantly steep dose-response curve, which means the drug's dosing is very important as small variance in dose can cause a significant difference in the biological response.

<span class="mw-page-title-main">Perrigo</span> Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.

Express Scripts Holding Company is a pharmacy benefit management (PBM) organization. In 2017 it was the 22nd-largest company in the United States by total revenue as well as the largest pharmacy benefit management (PBM) organization in the United States. Express Scripts had 2016 revenues of $100.752 billion. Since December 20, 2018, the company has been a direct subsidiary of Bloomfield, Connecticut-based Cigna.

An online pharmacy, internet pharmacy, or mail-order pharmacy is a pharmacy that operates over the Internet and sends orders to customers through mail, shipping companies, or online pharmacy web portal.

In the United States, a pharmacy benefit manager (PBM) is a third-party administrator of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans. According to the American Pharmacists Association, "PBMs are primarily responsible for developing and maintaining the formulary, contracting with pharmacies, negotiating discounts and rebates with drug manufacturers, and processing and paying prescription drug claims." PBMs operate inside of integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies.

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000.

Based on the National Council for Prescription Drug Programs standard, all pharmacy software systems contain information fields for both a primary and secondary insurer to pay for patient's prescription. The co-pay card appeared in 2005 as a means by which pharmaceutical marketers could, by offering an instantaneous rebate to patients, combat their challenges to prescription pharmaceuticals, including generic competition, lack of patient compliance and persistency, and an access to the physician population. As of January 2017, in the United States, coupon cards for more than 600 prescription medications are available.

Catamaran Corporation is the former name of a company that now operates within UnitedHealth Group's OptumRX division. It sells pharmacy benefit management and medical record keeping services to businesses in the United States and to a broad client portfolio, including health plans and employers. Working independently of the government and insurance companies allowed it to operate as a third party verifier; the RxCLAIM online claim processing system allowed for prescription drug claims to be processed online if the customer lived in and filled his/her prescription in the United States. SXC had three separate but interrelated business segments which dealt with prescription drug programs. For 2013, 23% of company revenue came from Cigna Corporation.

<span class="mw-page-title-main">J. Michael Pearson</span>

J. Michael Pearson is a Canadian American pharmaceutical company executive. He is the former chairman and CEO of Valeant Pharmaceuticals International after being ousted in the aftermath of a report on pharmaceutical pricing published by Citron Research in April 2016.

<span class="mw-page-title-main">Efinaconazole</span> Chemical compound

Efinaconazole, sold under the brand name Jublia among others, is a triazole antifungal medication. It is approved for use in the United States, Canada, and Japan as a 10% topical solution for the treatment of onychomycosis. Efinaconazole acts as a 14α-demethylase inhibitor.

Specialty drugs or specialty pharmaceuticals are a recent designation of pharmaceuticals classified as high-cost, high complexity and/or high touch. Specialty drugs are often biologics—"drugs derived from living cells" that are injectable or infused. They are used to treat complex or rare chronic conditions such as cancer, rheumatoid arthritis, hemophilia, H.I.V. psoriasis, inflammatory bowel disease and hepatitis C. In 1990 there were 10 specialty drugs on the market, around five years later nearly 30, by 2008 200, and by 2015 300.

Specialty pharmacy refers to distribution channels designed to handle specialty drugs — pharmaceutical therapies that are either high cost, high complexity and/or high touch. High touch refers to higher degree of complexity in terms of distribution, administration, or patient management which drives up the cost of the drugs. In the early years specialty pharmacy providers attached "high-touch services to their overall price tags" arguing that patients who receive specialty pharmaceuticals "need high levels of ancillary and follow-up care to ensure that the drug spend is not wasted on them." An example of a specialty drug that would only be available through specialty pharmacy is interferon beta-1a (Avonex), a treatment for MS that requires a refrigerated chain of distribution and costs $17,000 a year. Some specialty pharmacies deal in pharmaceuticals that treat complex or rare chronic conditions such as cancer, rheumatoid arthritis, hemophilia, H.I.V. psoriasis, inflammatory bowel disease (IBD) or Hepatitis C. "Specialty pharmacies are seen as a reliable distribution channel for expensive drugs, offering patients convenience and lower costs while maximizing insurance reimbursements from those companies that cover the drug. Patients typically pay the same co-payments whether or not their insurers cover the drug." As the market demanded specialization in drug distribution and clinical management of complex therapies, specialized pharma (SP) evolved.„ Specialty pharmacies may handle therapies that are biologics, and are injectable or infused. By 2008 the pharmacy benefit management dominated the specialty pharmacies market having acquired smaller specialty pharmacies. PBMs administer specialty pharmacies in their network and can "negotiate better prices and frequently offer a complete menu of specialty pharmaceuticals and related services to serve as an attractive 'one-stop shop' for health plans and employers."

Diplomat Pharmacy, Inc. is the largest independent provider of specialty pharmacy services in the United States. The company partners with manufacturers, payers, providers, hospitals, and more. Headquartered in Flint, Michigan, Diplomat has facilities across the United States and dispenses drugs in all 50 states. Diplomat offers specialized medication and medication management programs for patients with complex and chronic conditions such as cancer, hepatitis, multiple sclerosis, HIV and others.

References

  1. 1 2 3 Lopez, Linette (23 October 2015). "The secret firm at the heart of Valeant's crisis has an alleged history of shady behavior with customers". Business Insider. Retrieved 1 November 2015.
  2. 1 2 3 4 5 6 7 Rapoport, Michael (29 October 2015). "Valeant Countersues R&O Pharmacy Billing dispute draws attention to drug maker's work with specialty pharmacies" . Retrieved 1 November 2015.
  3. ↑ "Philidor". Better Business Bureau. 2014. Retrieved 1 November 2015.
  4. 1 2 Armstrong, Drew; Kitamura, Makiko (30 October 2015). "Valeant Says It's Cutting Ties With Troubled Pharmacy Philidor". Bloomberg. Retrieved 31 October 2015.
  5. 1 2 3 "Valeant Pharmaceuticals International Inc cuts ties with Philidor as business practice controversy grows". Bloomberg News. 30 October 2015. Retrieved 1 November 2015.
  6. 1 2 3 4 5 6 Peterson, Melody; Pfeifer, Stuart (1 November 2015), "A Troubling RX", Los Angeles Times, retrieved 1 November 2015
  7. ↑ "Overview". BQ6 Media Group. Philadelphia, PA. nd. Retrieved 2 November 2015.
  8. ↑ "Introduction". BQ6 Media Group. Philadelphia, PA. nd. Retrieved 2 November 2015.
  9. 1 2 3 Boyd, Roddy (19 October 2015). "The King's Gambit: Valeant's Big Secret". SIRF. Retrieved 4 November 2015.
  10. 1 2 "Game theory end game". BQ6 Media Group. Philadelphia, PA. nd. Retrieved 2 November 2015.
  11. ↑ "What we do". BQ6 Media Group. Philadelphia, PA. nd. Retrieved 2 November 2015.
  12. ↑ Müller, Karsten; Lamprecht, Frank (2001), Fundamental Chess Endings, Gambit Publications, ISBN   1-901983-53-6
  13. 1 2 Marotte, Bertrand (27 October 2015). "Valeant's sales network: Deciphering a complex web of companies". The Globe and Mail. Retrieved 4 November 2015.
  14. ↑ "State & County QuickFacts". U.S. Department of Commerce. 2010. Archived from the original on 5 September 2015. Retrieved 1 November 2015.
  15. ↑ "Philidor Statement Issues". Propublica. 18 December 2014. Retrieved 1 November 2015.
  16. ↑ Van Praet, Nicolas (27 October 2015). "L.A. pharmacy's legal battle could have huge consequences for Valeant". The Globe and Mail. Montreal. Retrieved 1 November 2015.
  17. ↑ Langreth, Robert; Deprez, Esmé E. (29 October 2015). "The Tiny Pharmacy at the Center of Valeant's Money Mystery". Bloomberg. Retrieved 1 November 2015.
  18. ↑ Chelsey Dulaney (May 6, 2015). "Alexion to Buy Synageva for $8.4 Billion". The Wall Street Journal. Retrieved May 7, 2015.
  19. 1 2 3 "Valeant Pharmaceuticals Announces FDA Approval Of Jublia® for the Treatment of Onychomycosis". Valeant Pharmaceuticals. Laval, Quebec. 9 June 2014. Archived from the original on 8 November 2015. Retrieved 1 November 2015.
  20. 1 2 "Valeant Pharmaceuticals Announces Approval of Retin-A Micro® Microsphere 0.08%". Valeant Pharmaceuticals. Laval, Quebec. 31 January 2014. Archived from the original on 15 February 2014. Retrieved 1 November 2015.
  21. ↑ Rockoff, Jonathan D.; Whalen, Jeanne (28 October 2015). "Pharmacy's Sales Tactics Disclosed". Dow Jones News. Retrieved 1 November 2015.
  22. ↑ Ornstein, Charles (22 October 2015). "Documents Raise New Questions About Valeant's Pharmacy Relationships in California". ProPublica. Retrieved 1 November 2015.
  23. ↑ Ingram, David (25 October 2015). "Legal tangle in California may shed light on specialty pharmacies". New York: Reuters. Retrieved 1 November 2015.
  24. 1 2 Beasley, Deena (30 October 2015). "Exclusive: Beyond Valeant, U.S. payers scrutinize other drugmaker ties to pharmacies". Los Angeles: Reuters. Retrieved 1 November 2015.
  25. 1 2 3 Armstrong, Drew (22 October 2015). "Valeant shares extend slide as long-time bull downgrades drug maker". The Globe and Mail. Retrieved 22 October 2015.
  26. 1 2 Rockoff, Jonathan D.; Whalen, Jeanne. "Valeant and Pharmacy More Intertwined Than Thought". Wall Street Journal. ISSN   0099-9660 . Retrieved 1 November 2015.
  27. ↑ "EXPRESS SCRIPTS HOLDING COMPANY FORM 10-K" . Retrieved 2013-11-20.
  28. ↑ van der Linde, Damon (22 October 2015). "Valeant stocks plunge, trading halted". Calgary Herald. Retrieved 22 October 2015.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.